Monitoring and evaluation

High-grade cervical lesions

  • Among all diagnostic procedures, 20% are diagnosed with HSIL+, while this is the case with 66% of therapeutic procedures.
  • Around 90% of women with HSIL+ biopsy have another invasive procedure (mainly therapeutic) preformed in one year period. HSIL+ is detected in almost 90% of follow-up therapeutic procedures.
  • On average, 1600 women per year were newly diagnosed with CIN2+ in the past three years, 1522 in the target age group 20-64.

 

Table: Number of newly diagnosed CIN2+ cases by age group*

 201720182019
0-19022
20-29384374390
30-39575549524
40-49346360373
50-64243226222
65+766786
Total (20-64)154815091509
Total (all ages)162415781597

*A newly diagnosed CIN2+ case in this table is defined as histopathologicaly confirmed CIN2+, followin a diagnostic or therapeutic invasive procedure (hysterectomies excluded), in a patient without such diagnosis in the past 3 years.

 

 

Jerman T, Ivanuš U, Florjančič M. ZORA Programme Monitoring and Evaluation. ZORA: Slovenian National Cervical Cancer Screening Programme and Registry. 2021. https://zora.onko-i.si/en/monitoring-and-evaluation/.

Accessibility(CTRL+F2)
color contrast
text size
highlighting content
zoom in